BSE filing, NSE: ALKYLAMINE. Summary written from the filing by ALFA Finder's alert engine.
Alkyl Amines Chemicals Ltd: key numbers
- Share price
- ₹1,651.90
- Market cap
- ₹8,449 Cr
- Revenue (annual)
- ₹1,536 Cr
- Net profit (annual)
- ₹180.0 Cr
- P/E (TTM)
- 37.5×Sector 34.1×
- Promoter holding
- 72.04%+0.00% QoQ
- FII holding
- 3.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Alkyl Amines Chemicals Ltd
All →Alkyl Amines Chemicals Other Announcement
Alkyl Amines Chemicals Ltd submitted its quarterly shareholding pattern in compliance with SEBI regulations. This filing discloses the current ownership structure of the company.
Alkyl Amines Chemicals Board Meeting Date
Alkyl Amines Chemicals Ltd has scheduled a Board Meeting on November 3, 2026, to consider and approve its unaudited financial results for the quarter ended September 30, 2026.
Alkyl Amines Chemicals Price Movement Clarification
Alkyl Amines Chemicals responded to NSE's volume-surge query, stating no undisclosed information exists. The company confirmed all Regulation 30 disclosures are complete.
Alkyl Amines Chemicals Annual General Meeting
Alkyl Amines Chemicals Limited announced postal ballot results, with members approving all special resolutions regarding leadership re-designations and director commission authorization.
Alkyl Amines Chemicals Other Announcement
Designated Person Ramchandra Narayan Iyer sold 2,800 shares of Alkyl Amines Chemicals Ltd, valued at approximately Rs. 0.57 Crore, via a market sale.
- Value
- ₹0.57 Cr
Alkyl Amines Chemicals Promoter Selling: ₹0.98 Cr
Director Rakesh Goyal of Alkyl Amines Chemicals Ltd sold 5,000 equity shares worth ₹0.98 Crore via market sale on August 19, 2026.
- Value
- ₹0.98 Cr
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.